Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
94 institutional managers report a position in Assembly Biosciences, Inc. worth $516.5M between them, filed on form 13F for the quarter ending 2026-06-30. 14 of them hold 80% of it, the largest being Gilead Sciences Inc at 26.48%.
69 more managers in the register
14 managers hold 80% of the $516.5M institutional base. The other 80 hold the rest.
Positions as filed with the SEC for the quarter ended Jun 30. A 13F is due 45 days after the quarter closes, so this register is 78 days old and does not move with the price above it.
via Gilead Sciences Inc, Woodline Partners LP, Parkman Healthcare Partners LLC +1 more · 26.48% of ASMB, 25.52% of RCUS
via Gilead Sciences Inc, Point72 Asset Management, L.P. · 26.48% of ASMB, 51.36% of LKFT
via Paradigm Biocapital Advisors LP, RA Capital Management, LLC, Jupiter Topco LLC +4 more · 8.27% of ASMB, 8.53% of EWTX
via Commodore Capital LP, RA Capital Management, LLC, Paradigm Biocapital Advisors LP +2 more · 7.53% of ASMB, 7.36% of EDIT
via Farallon Capital Management LLC, RA Capital Management, LLC, Jupiter Topco LLC +3 more · 8.54% of ASMB, 5.52% of JATT
via RA Capital Management, LLC, Jupiter Topco LLC, Commodore Capital LP +7 more · 5.43% of ASMB, 17.47% of TYRA
Managers holding a meaningful stake in ASMB also hold this much of the other company’s institutional base. Managers who hold most of the companies we cover are excluded, because their overlap says nothing about this one in particular. This is how the two are held, not evidence that one moves the other.
Prev close 26.08 · gapped above the open, then crossed back over prior close. High/low 29.83 at 8:30 am ET, 25.87 at 3:30 pm ET.
Assembly Biosciences, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Pharmaceutical Preparations
ASMB (Assembly Biosciences, Inc.) has 1 disclosed suppliers and 2 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
Largest move on the map today: ABUS −1.58%, in healthcare.